Abstract
Background
Systemic inflammatory response is strongly linked to among cancer development, progression and poor prognosis. The aim of this study was to clarify the impact of postoperative serum C-reactive protein (CRP) levels on the prognoses of patients with colorectal cancer (CRC).
Methods
A total of 467 patients with stage I–III CRC who underwent curative surgery were retrospectively analyzed. To precisely evaluate the effect of postoperative inflammatory status on prognosis in CRC patients, we excluded patients with postoperative complication or elevated preoperative CRP level (CRP > 1.0 mg/dL). Patients were divided into two groups based on their highest post-resection CRP levels (max CRP): the low CRP group (LCG; < 9.0 mg/dL, n = 385) and high CRP group (HCG; ≥ 9.0 mg/dL, n = 82). Furthermore, the effect of inflammation on malignant potential of CRC cells was evaluated using in vitro peritoneal dissemination model.
Results
HCG patients showed significantly worse recurrence-free survival (RFS) than LCG patients (p = 0.012). Multivariate analysis revealed that a higher max CRP was an independent prognostic factor for RFS (HR: 2.07, 95% CI 1.04–3.96, p = 0.038). Concerning the risk factors for high max CRP level, multivariate analysis revealed that older age (p < 0.001), male sex (p < 0.001), higher BMI (p = 0.005), right-sided colorectal cancer (p = 0.008), and longer operative time (p = 0.007) were independent risk factors. A higher max CRP was also significantly associated with peritoneal recurrence (p < 0.001). Additionally, recombinant cytokines enhanced the adhesive ability of CRC cells to mesothelial cell in vitro (p < 0.05).
Conclusions
Postoperative inflammation may be a possible mechanism portending the poor prognosis of CRC patients.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30
Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Center for Cancer Control and Information Services, National Cancer Center, Japan. Statistics. https://ganjoho.jp/reg_stat/statistics/index.html. Accessed 3 Dec 2017
Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444
Yamamura K, Sugimoto H, Kanda M et al (2014) Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci 21(9):682–688
Kubota T, Hiki N, Nunobe S et al (2012) Significance of the inflammation-based Glasgow prognostic score for short- and long-term outcomes after curative resection of gastric cancer. J Gastrointest Surg 16(11):2037–2044
Rossi S, Basso M, Strippoli A et al (2017) Are markers of systemic inflammation good prognostic indicators in colorectal cancer? Clin Colorectal Cancer 16(4):264–274. https://doi.org/10.1016/j.clcc.2017.03.015(epub 2017 Mar 24)
Kubota T, Hiki N, Sano T et al (2014) Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol 21:891–898
Lerut T, Moons J, Coosemans W et al (2009) Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg 250:798–807
Artinyan A, Orcutt ST, Anaya DA et al (2015) Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg 261:497–505
Lippitz BE (2013) Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 14:e218–e228
Alonso S, Pascual M, Salvans S et al (2015) Postoperative intra-abdominal infection and colorectal cancer recurrence: a prospective matched cohort study of inflammatory and angiogenic responses as mechanisms involved in this association. Eur J Surg Oncol 41:208–214
Di Caro G, Carvello M, Pesce S et al (2016) Circulating inflammatory mediators as potential prognostic markers of human colorectal cancer. PLoS ONE 11:e0148186
Sparreboom CL, Wu Z, Dereci A et al (2016) Cytokines as early markers of colorectal anastomotic leakage: a systematic review and meta-analysis. Gastroenterol Res Pract 2016:3786418
Yamamoto T, Umegae S, Matsumoto K et al (2011) Peritoneal cytokines as early markers of peritonitis following surgery for colorectal carcinoma: a prospective study. Cytokine 53:239–242
Herwig R, Glodny B, Kühle C et al (2002) Early identification of peritonitis by peritoneal cytokine measurement. Dis Colon Rectum 45:514–521
Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331:1565–1570
Castoldi G, Galimberti S, Riva C et al (2007) Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clin Sci (Lond) 113:103–108
Kim DK, Oh SY, Kwon HC et al (2009) Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9:155
Ikonomidis I, Andreotti F, Economou E et al (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100:793–798
Watanabe T, Muro K, Ajioka Y et al (2017) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. https://doi.org/10.1007/s10147-017-1101-6(Online March 27)
Sobin LH, Gospodarowicz MK, Wittekind Ch (eds) (2009) TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Hoboken
Japanese Society for Cancer of the Colon and Rectum (2013) Japanese classification of colorectal carcinoma, 8th edn. Kanehara & CO., LTD, Tokyo
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196
Forrest LM, McMillan DC, McArdle CS et al (2003) Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89(6):1028–1230
Ahmed D, Eide PW, Eilertsen IA et al (2013) Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2:e71. https://doi.org/10.1038/oncsis.2013.35
Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835
Shishido Y, Fujitani K, Yamamoto K et al (2016) C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer 19(1):293–301. https://doi.org/10.1007/s10120-014-0455-y(epub 2015 Jan 6)
Warschkow R, Tarantino I, Torzewski M et al (2011) Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients. Int J Colorectal Dis 26(11):1405–1413. https://doi.org/10.1007/s00384-011-1262-0(epub 2011 Jun 24)
Matsuda S, Takeuchi H, Kawakubo H et al (2015) Correlation between intense postoperative inflammatory response and survival of esophageal cancer patients who underwent transthoracic esophagectomy. Ann Surg Oncol 22:4453–4460
Ibuki Y, Hamai Y, Hihara J et al (2017) Role of postoperative C-reactive protein levels in predicting prognosis after surgical treatment of esophageal cancer. World J Surg 41:1558–1565
Saito T, Kurokawa Y, Miyazaki Y et al (2015) Which is a more reliable indicator of survival after gastric cancer surgery: postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol 112(8):894–899. https://doi.org/10.1002/jso.24067(epub 2015 Oct 13)
Shiba H, Furukawa K, Fujiwara Y et al (2013) Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma. Anticancer Res 33:705–709
Lu CY, Uen YH, Tsai HL et al (2011) Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Br J Cancer 104:1178–1184
Cathcart JM, Banach A, Liu A et al (2016) Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression. Oncotarget 7:61107–61120
Li Y, Wang L, Pappan L et al (2012) IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer 11:87
Nagasaki T, Hara M, Nakanishi H et al (2014) Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction. Br J Cancer 110:469–478
De Simone V, Franzè E, Ronchetti G et al (2015) Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene 34:3493–3503
Salvans S, Mayol X, Alonso S et al (2014) Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro. Ann Surg 260:939–943 (discussion 943–944)
Saltzstein SL, Behling CA (2007) Age and time as factors in the left to right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 41:173–177
Powell AG, Wallace R, McKee RF et al (2012) The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer. Colorectal Dis 14:1493–1499
Benedix F, Kube R, Meyer F et al (2010) Colon/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right and left sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53:57–64
Guinney J, Dienstmann R, Wang X et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21(11):1350–1356. https://doi.org/10.1038/nm.3967(epub 2015 Oct 12)
Arita T, Ichikawa D, Konishi H et al (2015) Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy. Ann Surg Oncol 22:758–766
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867 (review)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Matsubara, D., Arita, T., Nakanishi, M. et al. The impact of postoperative inflammation on recurrence in patients with colorectal cancer. Int J Clin Oncol 25, 602–613 (2020). https://doi.org/10.1007/s10147-019-01580-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-019-01580-1